supported by grants from the Cancer Prevention Research Institute of Texas(RP130266);the Carson-Leslie Foundation and the Association for Research of Childhood Cancer
Endocrine therapy using estrogen receptor-u (ER-α) antagonists for attenuating horm2one-driven cell proliferation is a major treatment modality for breast cancers. To exploit any DNA repair deficiencies associated ...